Oncology Medical Director - Cell and Gene Therapy Leader

CTI Clinical Trial and Consulting Services; Covington (KY); Hybride; USD 180 000 - 260 000; Plein temps

Résumé du poste

CTI Clinical Trial and Consulting Services seeks a Medical Director to lead medical strategy and safety across awarded trials, with emphasis on cell and gene therapy, fostering cross-functional collaboration and a clear therapeutic vision.

The role calls for board-certified physicians with 3+ years in clinical research, deep knowledge of ICH-GCP, trial design and regulatory processes, and the ability to guide biostatistics, data interpretation, and sponsor communications in a fast-paced CRO

Qualifications

• Board-certified physician with medical degree from an accredited school.
• At least 3 years of clinical research/clinical development experience.
• Knowledge of ICH-GCP, clinical trial design, statistics, and regulatory/clinical development process.
• Previous CRO or industry experience preferred.

Responsabilités

• Provide medical oversight of awarded clinical trials and safety monitoring.
• Lead lifecycle activities from early engagement to trial execution and delivery.
• Collaborate with regulatory, safety, and cross-functional teams to ensure protocol alignment and regulatory readiness.
• Develop business development input, including protocol design and development plans for sponsors.
• Guide proposal development, site and country selection, and patient recruitment strategies.

Connaissances

Leadership

Medical expertise

Clinical research

Regulatory knowledge

Communication skills

Strategic thinking

Team management

Formation

Medical degree from an accredited school

Board-certified physician

Description du poste

CTI Clinical Trial and Consulting Services seeks a Medical Director to lead medical strategy and safety across awarded trials, with emphasis on cell and gene therapy, fostering cross-functional collaboration and a clear therapeutic vision.

The role calls for board-certified physicians with 3+ years in clinical research, deep knowledge of ICH-GCP, trial design and regulatory processes, and the ability to guide biostatistics, data interpretation, and sponsor communications in a fast-paced CRO